|
Preliminary Program Outline
|
Back to Annual Meeting Program
< 2010 Program Index
| WEDNESDAY, MAY 5, 2010 |
| 7:00 a.m. |
|
Emerging Technologies & Techniques Forum
Hall C, Metro Toronto Convention Centre
(6 Minutes Presentation, 5 Minutes Discussion)
Moderators:
Joseph E. Bavaria, MD
Bryan F. Meyers, MD |
| |
|
T1. Continuing Experience with a Repositionable Inflatable Transcatheter Valve: Direct Flow Medical One Year and Beyond
Hendrik Treede1, Thilo Tuebler2, Hermann Reichenspurner1, Eberhard Grube3, Andrea Pascotto2, Olaf Franzen1, Ralf Mueller3, Reginald Low4, Steven F. Bolling5, Thomas Meinertz1, Joachim Schofer2
1. Department of Cardiovascular Surgery and Department of Cardiology, University Heart Center Hamburg, Hamburg, Germany. 2. Medical Care Center Prof. Mathey, Prof Schofer, Hamburg University Cardiovascular Center, Hamburg, Germany. 3. Department of Cardiology Angiology, HELIOS Heart Center Siegburg, Siegburg, Germany. 4. Division of Cardiovascular Medicine, University of California Davis Medical Center, Sacramento, CA, USA. 5. University of Michigan Cardiovascular Center, Ann Arbor, MI, USA.
T2. Sutureless Aortic Valve Replacement with the Trilogy Trilobal Aortic Valve System-Multicenter Experience
Ingo Breitenbach1, Jerzy Sadowski3 Gerhard Wimmer-Greinecker5, Christoph Schmitz2, Leo A. Bockeria4, Krzysztof Bartus3, Ravil M. Muratov4, Wolfgang Harringer1
1. Department of Thoracic and Cardiovascular Surgery, Klinikum Braunschweig, Braunschweig, Germany. 2. Department of Cardiac Surgery, University of Munich, Munich, Germany. 3. Department of Cardiovascular Surgery and Transplantology, Jageillonian University, Krakow, Poland. 4. Bakoulev Scientific Center for Cardiovascular Surgery, Moscow, Russia. 5. Department of Thoracic and Cardiovascular Surgery, Herzund Gefässzentrum Bad Bevensen, Bad Bevensen, Germany.
T3. Closed Chest Intra-Cardiac Mitral Valve Repair with the Mitraclip System by the Valve Interventionalist: Interventional Cardiologists or Cardiac Surgeons at a Single Center
Scott Lim1, Gorav Ailawadi2, Michael Ragosta3, John A. Kern2, John Dent3, Linda G. Bailes, Irving L. Kron2
1. Medicine & Pediatrics, University of Virginia, Charlottesville, VA, USA. 2. Surgery, University of Virginia, Charlottesville, VA, USA. 3. Medicine, University of Virginia, Charlottesville, VA, USA.
T4. A Fluid Diode for Control of Pulmonary Insufficiency
Tain-Yen Hsia1, Tiffany Camp2, Tim McQuinn3, Richard S. Figliola2
1. Cardiothoracic Surgery, Medical University of South Carolina, Charleston, SC, USA. 2. Mechanical Engineering, Clemson University, Clemson, SC, USA. 3. Pediatrics, University of Washington, Seattle, WA, USA.
T5. Truly Stentless Autologous Pericardial AVR: An Alternative to Standard AVR
K. M. John Chan, Jemyrr Therese A. Gavino, Gilles D. Dreyfus
Cardiothoracic Surgery, Royal Brompton and Harefield NHS Foundation Trust, Harefield, United Kingdom.
T6. Effect of Transapical Aortic Valve Implantation for Aortic Stenosis on Severity of Mitral Regurgitation
Robert L. Smith2, Arnaud Van Linden1, Joerg Kempfert1, Ines Schimpke1, Gerhard Schuler1, Friedrich W. Mohr1, Thomas Walther1
1. Department of Cardiac Surgery, Heart Center, University of Leipzig, Leipzig, Germany. 2. Cardiopulmonary Research Science and Technology Institute, Dallas, TX, USA.
T7. Transapical Transcatheter Mitral Valve-in-Valve Implantation: A Case Series
Anson Cheung, Jian Ye, John Webb, David A. Wood, Ronald G. Carere, Christopher Thompson, Samuel V. Lichtenstein
University of British Columbia, Vancouver, BC, Canada.
T8. Extra Corporeal Membrane Oxygenation via Cannulation of the Internal Jugular Vein with a Dual-Lumen Single Catheter System: A Novel Approach for the Treatment of End-Stage Lung Disease
Zachary N. Kon, Amod Tendulkar, Zhongjun Wu, Aldo T. Iacono, Brian McCormick, Bartley P. Griffith, Jose P. Garcia
University of Maryland School of Medicine, Baltimore, MD, USA.
T9. Preliminary Results of Anatomic Lung Resection Utilizing Energy Based Tissue and Vessel Coagulative Fusion Technology
Matthew J. Schuchert, Ghulam Abbas, Brian L. Pettiford, James D. Luketich, Rodney J. Landreneau
Heart, Lung and Esophageal Surgery Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
T10. The Novel Use of Coil Spring Fiducials Placed via Navigation Bronchoscopy in Inoperable Patients Allows for the Safe and Effective Delivery of Cyberknife Stereotactic Radiation
Carsten Schroeder1, Rana Hejal2, Philip Linden1
1. Thoracic & Esophageal Surgery, Case Medical Center, Cleveland, OH, USA. 2. Pulmonary Critical Care & Sleep Medicine, Case Medical Center, Cleveland, OH, USA. |
| |
| 9:00 a.m. - 10:00 a.m. |
|
PLENARY SESSION: CONTROVERSIES IN CARDIOTHORACIC SURGERY
Hall C, Metro Toronto Convention Centre
Randomized Controlled Clinical Trials are Necessary to Evaluate New Surgical Operations Moderator: Irving L. Kron, MD
Pro: Timothy J. Gardner, MD
Con: Joel D. Cooper, MD |
| |
| Simultaneous Sessions |
| 10:00 a.m. – 12:00 p.m. |
|
ADULT CARDIAC: SURGICAL THERAPIES FOR CONGESTIVE HEART FAILURE
Constitution 107, Metro Toronto Convention Centre
Chairs:
Vivek Rao, MD, PhD
Toronto General Hospital
Thoralf M. Sundt, III, MD
Mayo Clinic
COURSE OBJECTIVES
At the conclusion of this course, the participants will be able to:
| • |
Employ evidence-based medical management of heart failure patients presenting for cardiac surgical intervention. |
| • |
Understand the rationale and role of device therapy (ICD and CRT) for the postoperative management of patients with ischemic cardiomyopathy. |
| • |
Compare the medium and long-term outcomes of coronary bypass surgery, surgical ventricular reconstruction and mitral valve repair in patients with ischemic and non-ischemic cardiomyopathy. |
| • |
Implement optimal surgical therapy for patients with
end-stage heart disease. | |
| 10:00 a.m. – 10:20 a.m. |
|
Medical Management of CHF
“What the Surgeon Needs to Know”
Heather J. Ross, MD, MHSc
University of Toronto |
| 10:20 a.m. – 10:40 a.m. |
|
What is the Role of CRT and ICD after Cardiac Surgery?
Justin A. Mariani, MD
University of Toronto |
| 10:40 a.m. – 11:00 a.m. |
|
Life after STICH: When do we Repair the Dysfunctional LV?
Robert E. Michler, MD
Albert Einstein Medical College |
| 11:00 a.m. – 11:20 a.m. |
|
Mitral Repair in Non-Ischemic Cardiomyopathy: Is it a Viable Long-term Solution?
Steven F. Bolling, MD
University of Michigan |
| 11:20 a.m. – 11:40 a.m. |
|
Ventricular Restraint Therapies: Beyond Acorn and HeartNet
Michael A. Acker, MD
University of Pennsylvania |
| 11:40 a.m. – 12:00 p.m. |
|
Mechanical Circulatory Support in 2010: An Update
Nicholas G. Smedira, MD
Cleveland Clinic Foundation |
| 12:00 p.m. |
|
ADJOURN |
| |
| 10:00 a.m. – 12:00 p.m. |
|
GENERAL THORACIC: CONTROVERSIES IN THE UTILIZATION OF NEW TECHNOLOGY
Constitution 106, Metro Toronto Convention Centre
Chairs:
Thomas A. D’Amico, MD
Duke University
Shaf Keshavjee, MD, MSc
Toronto General Hospital
COURSE OBJECTIVES
At the conclusion of this course, the participants will be able to:
| • |
Identify the indications and technical aspects for ablative techniques for patients with Barrett’s esophagus. |
| • |
Determine the role for RFA or SBRT in marginally operable patients with Clinical Stage I non-small cell lung cancer. |
| • |
Utilize mediastinal staging techniques, including EBUS, mediastinoscopy, VAMLA and TEMLA, in appropriately selected patients with lung cancer. | |
|
|
Session I
Management of Barrett’s HGD and T1a Carcinoma
Moderator:
Gail E. Darling, MD
University of Toronto |
| 10:00 a.m. – 10:15 a.m. |
|
RFA, EMR and Other Ablative Techniques
Wayne Hofstetter, MD
MD Anderson Cancer Center |
| 10:15 a.m. – 10:30 a.m. |
|
Esophagectomy
Kemp H. Kernstine, MD, PhD
City of Hope National Medical Center |
| 10:30 a.m. – 10:40 a.m. |
|
DISCUSSION |
|
|
Session II
Management of Clinical Stage I NSCLC
Moderator:
Joseph B. Shrager, MD
Stanford University |
| 10:40 a.m. – 10:55 a.m. |
|
SBRT/RFA
Malcolm M. DeCamp, MD
Northwestern Memorial Hospital |
| 10:55 a.m. – 11:10 a.m. |
|
Thoracoscopic Lobectomy and Segmentectomy
Thomas D'Amico, MD
Duke University |
| 11:10 a.m. – 11:20 a.m. |
|
DISCUSSION |
|
|
Session III
Mediastinal Staging
Moderator:
G. Alec Patterson, MD
Washington University School of Medicine |
| 11:20 a.m. – 11:35 a.m. |
|
Role of EBUS
Kazuhiro Yasufuku, MD, PhD
Toronto General Hospital |
| 11:35 a.m. – 11:50 a.m. |
|
Mediastinosopy, VAMLA, TEMLA
Todd L. Demmy, MD
Roswell Park Cancer Institute |
| 11:50 a.m. – 12:00 p.m. |
|
DISCUSSION |
| 12:00 p.m. |
|
ADJOURN |
| |
| 10:00 a.m. – 12:00 p.m. |
|
CONGENITAL: NEW TECHNOLOGY IN CONGENITAL HEART DISEASE 
Constitution 105, Metro Toronto Convention Centre
Chair:
Christopher A. Caldarone, MD
The Hospital for Sick Children
COURSE OBJECTIVES
At the conclusion of this course, the participants will be able to:
| • |
Select patients appropriate for implantation of mechanical assist devices in children. |
| • |
Discuss future applications of cell-based therapies for
end-stage heart disease in the congenital population. |
| • |
Apply novel modalities of myocardial protection. | |
| 10:00 a.m. – 10:15 a.m. |
|
Intracardiac Surgery on the Beating Heart
Pedro J. del Nido, MD
Children’s Hospital Boston |
| 10:15 a.m. – 10:20 a.m. |
|
DISCUSSION |
| 10:20 a.m. – 10:35 a.m. |
|
Mechanical Assist for Single Ventricle Failure
Mark D. Rodefeld, MD
Indiana University |
| 10:35 a.m. – 10:40 a.m. |
|
DISCUSSION |
| 10:40 a.m. – 10:55 a.m. |
|
Automated Remote Ischemic Preconditioning in Pediatric Patients
Andrew N. Redington, MD
The Hospital for Sick Children |
| 10:55 a.m. – 11:00 a.m. |
|
DISCUSSION |
| 11:00 a.m. – 11:15 a.m. |
|
Robotic Surgery for Congenital Heart Disease
Johannes Bonatti, MD
University of Maryland |
| 11:15 a.m. – 11:20 a.m. |
|
DISCUSSION |
| 11:20 a.m. – 11:35 a.m. |
|
Real-time MRI Guided Procedures
Keith A. Horvath, MD
National Heart, Lung and Blood Institute |
| 11:35 a.m. – 11:40 a.m. |
|
DISCUSSION |
| 11:40 a.m. – 11:55 a.m. |
|
Cell-based Therapies for Congenital Heart Disease
Richard D. Weisel, MD |
| 11:55 a.m. – 12:00 p.m. |
|
DISCUSSION |
| 12:00 p.m. |
|
ADJOURN |
| |
| 1:00 p.m. – 5:00 p.m. |
|
ENDOBRONCHIAL ULTRASOUND (EBUS)
TRAINING COURSE
Toronto Medical Discovery Tower
MARS Large Animal OR
101 College St. Toronto
Chairs:
Shaf Keshavjee, MD, MSc
University of Toronto
Andrew Pierre, MD, MSc
University of Toronto
Kazuhiro Yasufuku, MD, PhD
University of Toronto
COURSE OBJECTIVES
At the conclusion of this course, the participants will be able to:
| • |
Describe the indications and limitations of various methods of mediastinal staging in lung cancer. |
| • |
List the indications for EBUS-TBNA, technique, risks and outcomes. |
| • |
Demonstrate familiarity with the EBUS-TBNA equipment and technical procedure. |
| • |
Possess technical skills required to perform a safe and successful EBUS-TBNA in a clinical setting. | |
| |
| 1:00 p.m. – 2:00 p.m. |
|
Welcome and Introduction
Shaf Keshavjee, MD, MSc
University or Toronto
EBUS-TBNA Procedure Results, Pig Anatomy
Kazuhiro Yasufuku, MD, PhD
University of Toronto |
| 2:00 p.m. – 5:00 p.m. |
|
Hands-on Session - Wet Lab
• Handling of Equipment
• Training with a Phantom
• EBUS-TBNA in Pigs
• Rapid Onsite Evaluation of Specimens
• Q & A
DISCUSSION
CLOSING REMARKS
Shaf Keshavjee, MD, MSc
|
| 5:00 p.m. |
|
ADJOURN |
< 2010 Preliminary Program Index
|
|
